Depletion of MRPL35 inhibits gastric carcinoma cell proliferation by regulating downstream signaling proteins

Table 1 Correlation of expression of MRPL35 with various clinicopathological features in 68 gastric carcinoma patients

Pathological feature	n	Expression of MRPL35
		High	Low	P value
	68	28	40
Gender
Male	48	19	29	0.685
Female	20	9	11
Age (yr)
< 65	33	18	15	0.03a
≥ 65	35	10	25
p-TNM stage
I/II	33	9	24	0.024a
III/IV	35	19	16
Size of tumour
≤ 5 cm	29	9	20	0.1
> 5 cm	39	19	20
Pathological T grade
T1/T2	11	3	8	0.313
T3/T4	57	25	32
Lymph node metastasis (pN)
N0/N1	30	7	23	0.007b
N2/N3	38	21	17

^aP < 0.05.

^bP < 0.01. p-TNM stage: Pathological tumor-node-metastasis stage.